Anti-SARS CoV-2-Spike [4E-1G]

The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in […]

Contributors

Inventor Institute
Bernhard Singer LeukoCom
Cat. #: 160701
Unit size: 100 ug
Research Fields: Microbiology
Application: ELISA ; IHC ; Fn ; WB
Target: SARS CoV-2 Spike
Reactivity: Virus
Host: Mouse
Class: Monoclonal
Product description: The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in the receptor recognition and cell membrane fusion process of the virus to host cells through it's interaction with the receptor ACE2.
Conjugation: Unconjugated
Isotype: IgG1 kappa
Immunogen: Recombinant SAR-CoV-2 spike-human Fc protein
Myeloma used: NS1/0
Target background: The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in the receptor recognition and cell membrane fusion process of the virus to host cells through it's interaction with the receptor ACE2.
Format: Liquid
Concentration: 0.9-1.1mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice

Images

View Gallery

Related Tools for Antibodies

Cat. # Tool Name
151021 Anti-CyclinB1 [V152] Key Info View Tool
151022 Anti-IL12 [1-1A4] Key Info View Tool
151028 Anti-Cytochrome P450 2C2, 2B1/2 [h7] Key Info View Tool
151031 Anti-RuvA [RuvA 12C6] Key Info View Tool
151035 Anti-CD8 [14] mAb Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.